Predictive Technology Debt to Equity Ratio 2017-2021 | PRED
Current and historical debt to equity ratio values for Predictive Technology (PRED) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Predictive Technology debt/equity for the three months ending March 31, 2021 was 0.00.
| Predictive Technology Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2021-03-31 | $0.04B | $0.03B | 1.10 |
| 2020-12-31 | $0.03B | $0.04B | 0.86 |
| 2020-09-30 | $0.03B | $0.04B | 0.76 |
| 2020-06-30 | $0.03B | $0.06B | 0.53 |
| 2020-03-31 | $0.02B | $0.09B | 0.26 |
| 2019-12-31 | $0.03B | $0.09B | 0.35 |
| 2019-09-30 | $0.03B | $0.11B | 0.28 |
| 2019-06-30 | $0.03B | $0.11B | 0.28 |
| 2019-03-31 | $0.03B | $0.11B | 0.22 |
| 2018-12-31 | $0.02B | $0.10B | 0.16 |
| 2018-09-30 | $0.02B | $0.10B | 0.18 |
| 2018-06-30 | $0.02B | $0.08B | 0.28 |
| 2018-03-31 | $0.00B | $0.00B | 0.00 |
| 2017-12-31 | $0.00B | $0.00B | 0.00 |
| 2017-09-30 | $0.00B | $0.00B | 0.00 |
| 2017-06-30 | $0.00B | $0.04B | 0.03 |
| 2016-06-30 | $0.00B | $0.04B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.000B | $0.000B |
| Predictive Technology Group, Inc. is a therapeutics and life sciences company, in the use of data analytics for disease identification and subsequent therapeutic intervention through unique novel gene-based diagnostics, biotechnology treatments and companion therapeutics. The company through its' wholly-owned subsidiaries Predictive Therapeutics and Predictive Biotech focuses on clinical categories consists of Endometriosis, Scoliosis, Degenerative Disc Disease and Regenerative Human Cell and Tissue Products. Predictive Biotech efforts to advance regenerative medicine and Predictive Therapeutics is committed to assisting women in overcoming the devastating consequences of endometriosis via appropriate early-stage diagnosis and subsequent treatment. Predictive Technology Group, Inc. is based in Salt Lake City, UT. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $37.115B | 20.38 |
| Inspire Medical Systems (INSP) | United States | $4.725B | 0.00 |
| Axonics (AXNX) | United States | $3.452B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.070B | 0.00 |
| 10x Genomics (TXG) | United States | $3.049B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $3.016B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.978B | 0.00 |
| Enovis (ENOV) | United States | $2.863B | 21.22 |
| Azenta (AZTA) | United States | $2.768B | 155.58 |
| Privia Health (PRVA) | United States | $2.028B | 113.33 |
| Schrodinger (SDGR) | United States | $1.664B | 0.00 |
| Omnicell (OMCL) | United States | $1.454B | 50.25 |
| Phreesia (PHR) | United States | $1.379B | 0.00 |
| Standard BioTools (LAB) | United States | $0.725B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.673B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.649B | 0.00 |
| Talkspace (TALK) | United States | $0.475B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.464B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.415B | 0.00 |
| Pulmonx (LUNG) | United States | $0.351B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.301B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.213B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.190B | 0.00 |
| Outset Medical (OM) | United States | $0.182B | 0.00 |
| American Well (AMWL) | United States | $0.144B | 0.00 |
| TruBridge (TBRG) | United States | $0.139B | 7.46 |
| 111 (YI) | China | $0.112B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.111B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.079B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.068B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.067B | 0.00 |
| Augmedix (AUGX) | United States | $0.060B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.057B | 0.00 |
| HeartBeam (BEAT) | United States | $0.056B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| Movano (MOVE) | United States | $0.043B | 0.00 |
| CareCloud (CCLD) | United States | $0.040B | 0.00 |
| Akili (AKLI) | United States | $0.034B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.029B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| Cue Health (HLTH) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Syra Health (SYRA) | United States | $0.011B | 0.00 |
| Biotricity (BTCY) | United States | $0.010B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |